Document:

THIS
NOTE AND THE COMMON STOCK ISSUABLE UPON CONVERSION OF TIDS NOTE HAVE NOT BEEN AND WILL NOT BE REGISTERED WITH THE UNITED STATES
SECURITIES AND EXCHANGE COMMISSION OR THE SECURITIES COMMISSION OF ANY STATE PURSUANT TO AN EXEMPTION FROM REGISTRATION PROVIDED
UNDER THE SECURITIES ACT OF 1933, AS AMENDED, AND THERULESANDREGULATIONS PROMULGATED THEREUNDER (THE "1933 ACT")

 

us
$40,000.00

 

REGEN
BIOPHARMA, INC.

8%
CONVERTIBLE REDEEMABLE NOTE

DUE
SEPTEMBER 7, 2018

 

 

FOR
VALUE RECEIVED, Regen Biopharma, Inc. (the "Company") promises to pay to the order of LG CAPITAL FUNDING, LLC and its
authorized successors and permitted assigns ("Holder"), the aggregate principal face amount of Forty Thousand
Dollars (U.S. $40,000.00) on September 7, 2018 ("Maturity Date") and to pay interest on the principal amount
outstanding hereunder at the rate of 8% per annum commencing on September 7, 2017. The interest will be paid to the Holder in
whose name this Note is registered on the records of the Company regard ing registration and transfers of this Note. The principal
of, and interest on, this Note are payable at 1218 Union Street, Suite #2, Brooklyn, NY 11225, initially, and if changed, last
appearing on the records of the Company as designated in writing by the Holder hereof from time to time. The Company will pay
each interest payment and the outstanding principal due upon this Note before or on the Maturity Date, less any amounts required
by law to be deducted or withheld, to the Holder of this Note by check or wire transfer addressed to such Holder at the last address
ap pearing on the records of the Company. The forwarding of such check or wire transfer shall con stitute a payment of outstanding
principal hereunder and shall satisfy and discharge the liability for principal on this Note to the extent of the sum represented
by such check or wire transfer. In terest shall be payable in Common Stock (as defined below) pursuant to paragraph 4(b) herein.

 

This
Note is subject to the following additional provisions:

 

1.                 
This Note is exchangeable for an equal aggregate principal amount of Notes of different authorized denominations, as requested
by the Holder surrendering the same. charge will be made for such registration or transfer or exchange, except that Holder shall
pay any tax or other governmental charges payable in connection therewith.

 

    	 	1	 

     

    

 

2.                 
The Company shall be entitled to withhold from all payments any amounts required to be withheld under applicable laws.

 

3.                  
This Note may be transferred or exchanged only in compliance with the Securities Act of 1933, as amended ("Act")
and applicable state securities laws. Any attempted transfer to a non-qualifying party shall be treated by the Company as
void. Prior to due present ment for transfer of this Note, the Company and any agent of the Company may treat the person in whose
name this Note is duly registered on the Company's records as the owner hereof for all other purposes, whether or not this Note
be overdue, and neither the Company nor any such agent shall be affected or bound by notice to the contrary. Any Holder of this
Note electing to exercise the right of conversion set forth in Section 4(a) hereof, in addition to the requirements set forth
in Section 4(a), and any prospective transferee of this Note, also is required to give the Company written confirmation that this
Note is being converted ("Notice of Conversion") in the form annexed hereto as Exhibit A. The date of
receipt (including receipt by telecopy) of such Notice of Conversion shall be the Conversion Date.

 

4.                  
(a) The Holder of this Note is entitled, at its option, at any time, to convert all or any amount of the principal face amount
of this Note then outstanding into shares of the Company's common stock (the "Common Stock") at a price ("Conversion
Price") for each share of Common Stock equal to 65% of the lowest trading price of the Common Stock as
re ported on the National Quotations Bureau OTC Market Exchange which the Company's shares are traded or any exchange upon which
the Common Stock may be traded in the future ("Ex change"), for the twenty
prior trading days including the day upon which a Notice of Conversion is received
by the Company or its transfer agent (provided such Notice of Conversion is deliv ered by fax or other electronic method of communication
to the Company or its transfer agent af ter 4 P.M. Eastern
Standard or Daylight Savings Time if the Holder wishes to include the same day closing price). If the shares have not been delivered
within 3 business days, the Notice of Conversion may be rescinded. Such conversion shall be effectuated by the Company delivering
the shares of Common Stock to the Holder within 3 business days of receipt by the Company of the Notice of Conversion. Accrued
but unpaid interest shall be subject to conversion. No frac tional shares or scrip representing fractions of shares will be issued
on conversion, but the num ber of shares issuable shall be rounded to the nearest whole share. To the extent the Conversion Price
of the Company's Common Stock closes below the par value per share, the Company will take all steps necessary to solicit the consent
of the stockholders to reduce the par value to the lowest value possible under law. The Company agrees to honor all conversions
submitted pend ing this increase. In the event the Company experiences a DTC "Chill" on its shares, the Con
version Price shall be decreased to 55% instead of 65% while that "Chill" is in effect. In
no event shall the Holder be allowed to effect a conversion if such conversion, along with all other shares of Company Common
Stock beneficially owned by the Holder and its affiliates would ex ceed 9.9% of the outstanding shares of the Common Stock of
the Company. All the terms set forth herein, including but not limited to interest rate, prepayment terms, conversion discount
or lookback period will be adjusted downward (i.e. for the benefit of the Holder) if the Company offers a more favorable conversion
discount (whether via interest, rate 01D or otherwise) or lookback period to another party or otherwise grants any more favorable
terms to any third party than those contained herein while this note is in effect.

 

    	 	2	 

     

    

 

(b)
Interest on any unpaid principal balance of this Note shall be paid at the rate of 8% per annum. Interest shall be paid by the
Company in Common Stock ("Interest Shares"). Holder may, at any time, send in a Notice of Conversion to the Company
for Interest Shares based on the formula provided in Section 4(a) above. The dollar amount converted into Interest Shares shall
be all or a portion of the accrued interest calculated on the unpaid principal balance of this Note to the date of such notice.

 

(c)
The Notes may be prepaid with the following penalties:

 

	Time
    Period	 	Payment
    Premium
	<=61
    days after note issuance	 	115%
    of the sum of principal plus accrued interest
	>61
    days <= 120 days after note issuance	 	125%
    of the sum of principal plus accrued interest
	>120
    days <=180 days after note issuance	 	135%
    of the sum of principal plus accrued interest

 

This
Note may not be prepaid after the 180th day. Such redemption must be closed and funded within 3 days of giving notice of redemption
of the right to redeem shall be null and void.

 

 

(d)              
Upon (i) a transfer of all or substantially all
of the assets of the Company to any person in a single transaction or series of related transactions, (ii) a reclassification,
capital reorganization or other change or exchange of outstanding shares of the Common Stock, other than a forward or reverse
stock split or stock dividend, or (iii) any consolidation or merger of the Company with or into another person or entity in which
the Company is not the surviving entity (other than a merger which is effected solely to change the jurisdiction of incorporation
of the Company and results in a reclassification, conversion or exchange of outstanding shares of Common Stock solely into shares
of Common Stock) (each of items (i), (ii) and (iii) being re ferred to as a "Sale Event"), then, in each case, the Company
shall, upon request of the Holder, redeem this Note in cash for 150% of the principal amount, plus accrued but unpaid interest
through the date of redemption, or at the election of the Holder, such Holder may convert the un paid principal amount of this
Note (together with the amount of accrued but unpaid interest) into shares of Common Stock immediately prior to such Sale Event
at the Conversion Price.

 

(e)               
In case of any Sale Event (not to include a sale
of all or substantially all of the Company's assets) in connection with which this Note is not redeemed or converted, the Company
shall cause effective provision to be made so that the Holder of this Note shall have the right thereafter, by converting this
Note, to purchase or convert this Note into the kind and number of shares of stock or other securities or property (including
cash) receivable upon such reclassification, capital reorganization or other change, consolidation or merger by a holder of the
number of shares of Common Stock that could have been purchased upon exercise of the Note and at the same Conversion Price, as
defined in this Note, immediately prior to such Sale Event. The foregoing provisions shall similarly apply to successive Sale
Events. If the considera tion received by the holders of Common Stock is other than cash, the value shall be as deter mined by
the Board of Directors of the Company or successor person or entity acting in good faith.

 

5.                  
No provision of this Note shall alter or impair the obligation of the Com- pany, which is absolute and unconditional, to pay the
principal of, and interest on, this Note at the time, place, and rate, and in the form, herein prescribed.

 

    	 	3	 

     

    

 

6.                 
The Company hereby expressly waives demand and presentment for pay- ment, notice of non-payment, protest, notice of protest, notice
of dishonor, notice of acceleration or intent to accelerate, and diligence in taking any action to collect amounts called for
hereunder and shall be directly and primarily liable for the payment of all sums owing and to be owing hereto.

 

7.                 
The Company agrees to pay all costs and expenses, including reasonable attorneys' fees and expenses, which may be incurred by
the Holder in collecting any amount due under this Note.

 

		8.	If
                                         one or more of the following described "Events of Default" shall occur:

 

(a)              
The Company shall default in the payment of principal
or interest on this Note or any other note issued to the Holder by the Company; or

 

(b)              
Any of the representations or warranties made
by the Company herein or in any certificate or financial or other written statements heretofore or hereafter furnished by or on
behalf of the Company in connection with the execution and delivery of this Note, or the Se curities Purchase Agreement under
which this note was issued shall be false or misleading in any respect; or

 

(c)               
The Company shall fail to perform or observe,
in any respect, any cove- nant, term, provision, condition, agreement or obligation of the Company under this Note or any other
note issued to the Holder; or

 

(d)              
The Company shall (1) become insolvent; (2) admit
in writing its inability to pay its debts generally as they mature; (3) make an assignment for the benefit of creditors or commence
proceedings for its dissolution; (4) apply for or consent to the appointment of a trus tee, liquidator or receiver for its or
for a substantial part of its property or business; (5) file a peti tion for bankruptcy relief, consent to the filing of such
petition or have filed against it an invol untary petition for bankruptcy relief, all under federal or state laws as applicable;
or

 

(e)               
A trustee, liquidator or receiver shall be appointed
for the Company or for a substantial part of its property or business without its consent and shall not be discharged with in
sixty (60) days after such appointment; or

 

(f)                
Any governmental agency or any court of competent
jurisdiction at the in- stance of any governmental agency shall assume custody or control of the whole or any substan tial portion
of the properties or assets of the Company; or

 

(g)              
One or more money judgments, writs or warrants
of attachment, or similar process, in excess of fifty thousand dollars ($50,000) in the aggregate, shall be entered or filed against
the Company or any of its properties or other assets and shall remain unpaid, unvacated, unbonded or unstayed for a period of
fifteen (15) days or in any event later than five (5) days prior to the date of any proposed sale thereunder; or

    	 	4	 

     

    

 

(h)             
The Company shall have defaulted on or breached
any term of any other note of similar debt instrument into which the Company has entered and failed to cure such de fault within
the appropriate grace period; or

 

(i)               
The Company shall have its Common Stock delisted
from an exchange (including the OTC Market exchange) or, if the Common Stock trades on an exchange, then trad ing in the Common
Stock shall be suspended for more than 10 consecutive days;

G)
If a majority
of the members of the Board of Directors of the Company on the date hereof are no longer serving as members of the Board;

 

(k)              
The Company shall not deliver to the Holder the Common Stock pursuant to paragraph 4 herein without restrictive legend within
3 business days of its receipt of a Notice of Conversion; or

 

(1)                
The Company shall not replenish the reserve set forth in Section 12, with- in 3 business days of the request of the Holder.

 

(m)           
The Company shall not be "current"
in its filings with the Securities and Exchange Commission; or

 

(n)              
The Company shall lose the "bid" price
for its stock in a market (including the OTC marketplace or other exchange).

 

Then,
or at any time thereafter, unless cured within 5 days, and in each and every such case, un less such Event of Default shall have
been waived in writing by the Holder (which waiver shall not be deemed to be a waiver of any subsequent default) at the option
of the Holder and in the Holder's sole discretion, the Holder may consider this Note immediately due and payable, with out presentment,
demand, protest or (further) notice of any kind (other than notice of accelera tion), all of which are hereby expressly waived,
anything herein or in any note or other instru ments contained to the contrary notwithstanding, and the Holder may immediately,
and without expiration of any period of grace, enforce any and all of the Holder's rights and remedies provid ed herein or any
other rights or remedies afforded by law. Upon an Event of Default, interest shall accrue at a default interest rate of 24% per
annum or, if such rate is usurious or not permit ted by current law, then at the highest rate of interest permitted by law. In
the event of a breach of Section 8(k) the penalty shall be $250 per day the shares are not issued beginning on the 4th
day after the conversion notice was delivered to the Company. This penalty shall increase to $500 per day beginning on the 10th
day. The penalty for a breach of Section 8(n) shall be an in crease of the outstanding principal amounts by 20%.
In case of a breach of Section 8(i), the out standing principal due under this Note shall increase by 50%. If this
Note is not paid at maturity, the outstanding principal due under this Note shall increase by 10%. Further, if a breach of Sec
tion 8(m) occurs or is continuing after the 6 month anniversary of the Note, then
the Holder shall be entitled to use the lowest closing bid price during the delinquency period as a base price for the conversion.
For example, if the lowest closing bid price during the delinquency period is $0.01 per share and the conversion discount
is 50% the Holder may elect to convert future con versions at $0.005 per share.

 

    	 	5	 

     

    

 

If
the Holder shall commence an action or proceeding to enforce any provisions of this Note, in cluding, without limitation, engaging
an attorney, then if the Holder prevails in such action, the Holder shall be reimbursed by the Company for its attorneys' fees
and other costs and expenses incurred in the investigation, preparation and prosecution of such action or proceeding.

 

Make-Whole
for Failure to Deliver Loss. At the Holder's election, if the Company fails for any reason to deliver to the Holder the conversion
shares by the by the 3rd business day following the delivery of a Notice of Conversion to the Company and if the Holder incurs
a Failure to Deliver Loss, then at any time the Holder may provide the Company written notice indicating the amounts payable to
the Holder in respect of the Failure to Deliver Loss and the Company must make the Holder whole as follows:

 

Failure
to Deliver Loss = [(Highest VWAP price for the 30 trading days on or after the day of exercise) x (Number of conversion shares)]

 

The
Company must pay the Failure to Deliver Loss by cash payment, and any such cash payment must be made by the third business day
from the time of the Holder's written notice to the Com pany.

 

9.                  
In case any provision of this Note is held by a court of competent jurisdic- tion to be excessive in scope or otherwise invalid
or unenforceable, such provision shall be ad justed rather than voided, if possible, so that it is enforceable to the maximum
extent possible, and the validity and enforceability of the remaining provisions of this Note will not in any way be affected
or impaired thereby.

 

10.             
Neither this Note nor any term hereof may be amended, waived, dis- charged or terminated other than by a written instrument signed
by the Company and the Holder.

 

11.             
The Company represents that it is not a "shell" issuer and has never been a "shell" issuer or that if it previously
has been a "shell" issuer that at least 12 months have passed since the Company has reported form 10 type information
indicating it is no longer a "shell issu er. Further. The Company will instruct its counsel to either (i) write a 144 opinion
to allow for salability of the conversion shares or (ii) accept such opinion from Holder's counsel.

 

12.           
The Company shall issue irrevocable transfer agent instructions reserving 6,003,000 shares of its Common Stock for conversions
under this Note (the "Share Reserve"). Upon full conversion of this Note, any shares remaining in the Share Reserve
shall be cancelled. The Company shall pay all costs associated with issuing and delivering the shares. If such amounts are to
be paid by the Holder, it may deduct such amounts from the Conversion Price. The company should at all times reserve a minimum
of four times the amount of shares required if the note would be fully converted. The Holder may reasonably request increases
from time to time to reserve such amounts. The Company will instruct its transfer agent to provide the out standing share information
to the Holder in connection with its conversions.

 

    	 	6	 

     

    

 

13.             
The Company will give the Holder direct notice of any corporate actions, including but not limited to name changes, stock splits,
recapitalizations etc. This notice shall be given to the Holder as soon as possible under law.

 

14.             
If it shall be found that any interest or other amount deemed interest due hereunder violates the applicable law governing usury,
the applicable provision shall automati cally be revised to equal the maximum rate of interest or other amount deemed interest
permitted under applicable law. The Company covenants (to the extent that it may lawfully do so) that it will not seek to claim
or take advantage of any law that would prohibit or forgive the Company from paying all or a portion of the principal or interest
on this Note.

 

15.             
This Note shall be governed by and construed in accordance with the laws of New York applicable to contracts made and wholly to
be performed within the State of New York and shall be binding upon the successors and assigns of each party hereto. The Holder
and the Company hereby mutually waive trial by jury and consent to exclusive jurisdiction and venue in the courts of the State
of New York or in the Federal courts sitting in the county or city of New York. This Agreement may be executed in counterparts,
and the facsimile transmission of an executed counterpart to this Agreement shall be effective as an original.

 

 

    	 	7	 

     

    

 

IN
WITNESS WHEREOF, the Company has caused this Note to be duly execut ed by an officer thereunto duly authorized.

 

	Dated: 9/11/2017	 	/s/ David R. Koos
	 	 	David R. Koos
	 	 	Chairman & CEO

 

 

    	 	8	 

     

    

 

EXHIBIT
A

 

NOTICE
OF CONVERSION

 

(To
be Executed by the Registered Holder in order to Convert the Note)

 

The
undersigned hereby irrevocably elects to convert $of
the above Note intoShares of Common Stock of Regen Biopharma, Inc. ("Shares") according to the conditions
set forth in such Note, as of the date written below.

 

If
Shares are to be issued in the name of a person other than the undersigned, the undersigned will pay all transfer and other taxes
and charges payable with respect thereto.

 

	Date of Conversion:	 	 
	Applicable Conversion Price:	 	 
	Signature:	 	 
	[Print
    Name of Holder and Title of Singer]
	Address:	 	 	 
	 	 	 	 
	SSN or EIN:	 	 	 
	Shares are to be registered in the
    following name:	 
	 	 	 	 
	Name:	 	 	 
	Tel:	 	 	 
	Fax:	 	 	 
	SSN or EIN:	 	 	 

 

Shares
are to be sent or delivered to the following account:

 

	Account Name:	 
	Address:	 

 

    	 	9This
Business Advisory Board Services Agreement (the "Agreement"), dated October 2, 2017, is entered into between Regen BioPharma,
Inc., a Nevada corporation ("the Company"), and Robert D. Hopkins, an individual with a principal place of residence
_______("Candidate").

WHEREAS,
the Company desires to retain the services of Candidate for the benefit of the Company and its stockholders; and

WHEREAS,
Candidate desires to serve as a member of the Company's Business Advisory Board for the period of time and subject to the
terms and conditions set forth herein;

NOW,
THEREFORE, for consideration and as set forth herein, the parties hereto agree as follows:

 

		1.	Board
                                         Duties. Candidate agrees to provide services to the Company as a member of the Company's
                                         Business Advisory Board. Candidate shall, for so long as he remains a member of the Business
                                         Advisory Board, meet with the Company upon written request, at dates and times mutually
                                         agreeable to Candidate and the Company, to discuss any matter involving the Company or
                                         its Subsidiaries

		2.	Other
                                         Duties. Candidate will utilize his best efforts to:

		(a)	Identify
                                         and introduce to the Company persons not previously known to the Company to serve as
                                         members of the Company's Business Advisory Board ("Advisory Candidates").

		(b)	Identify
                                         and introduce to the Company potential purchasers of the Company's securities, such purchasers
                                         not previously known to the Company ("Buyers"). Candidate shall solely identify
                                         and introduce Buyers to the Company and shall not, among other things, participate in
                                         any negotiations between a Buyer and the Company, assist in the structure of any offer
                                         or sale of the Company's securities ("Transaction"), provide assistance to
                                         any party in completing a purchase agreement, subscription agreement or other documentation
                                         related to a Transaction or handle the funds or securities involved in any Transaction.

		3.	Term.
                                         The Term of this Agreement shall commence on October 2, 2017 and shall expire on
                                         October 2, 2020. The term of this Agreement may be extended by mutual agreement.

		4.	Independent
                                         Contractor. The Parties are independent contractors. Nothing in this Agreement shall
                                         be deemed to constitute a partnership or joint venture between the Parties or constitute
                                         any Party to be the agent of the other Party for any purpose.

		5.	No
                                         obligation: This Agreement does not constitute an obligation on the part of the Company
                                         to:

		(a)	Enter
                                         into any Transaction with any Buyer

		(b)	Accept
                                         as a member of the Business Advisory Board any Advisory Candidate

    	 	1	 

     

    

 

		6.	Mutual
                                         Non-Disparagement. During the term of this Agreement and for a period of twelve months
                                         thereafter, Candidate and the Company mutually agree to forbear from making, causing
                                         to be made, publishing, ratifying or endorsing any and all disparaging remarks, derogatory
                                         statements or comments made to any party with respect to either of them or their respective
                                         officers, directors, and employees. The parties agree and acknowledge that this Section
                                         6 is a material term of this Agreement.

 

		7.	Non-Disclosure.

 

(a) 
All information, whether in oral, written, graphic,
electronic or other form, disclosed by the Company to the Candidate shall be deemed to be "Proprietary Information."
In particular, Proprietary Information includes, without limitation, any trade secrets, confidential information, ideas, inventions
or research and development information; matters of a technical nature, including technology; notes, products, know-how, engineering
or other data (including test data and data files); specifications, processes, techniques, formulae or work-in-process; manufacturing,
planning or marketing procedures, clinical data and regulatory strategies or information; accounting, financial or pricing procedures
or information, budgets or projections, or personnel or salary structure/compensation information; information regarding suppliers,
clients, customers, employees, contractors, investors or investigators of the Company, information which has been designated in
writing as confidential by the Company; programs, procedures (including operating procedures), processes, methods, guidelines,
policies, proposals or contracts; computer software, data bases or programming; and any other information which, if divulged to
a third party, could have an adverse impact on the Company, or on any third party to which it owes a confidentiality obligation.
In addition, "Proprietary Information" includes any of the foregoing relating to the past, present or future operations,
organization, projects, finances, business interests, methodology or affairs of any third party to which the Company owes a duty
of confidentiality including, without limitation, the mere fact that the Company is or may be working with or for any client.

 

(b)
The obligations of confidentiality shall not
apply to any Proprietary Information that was known by the Candidate at the time of disclosure to it by such Company, or that
is independently developed or discovered by the Candidate after disclosure by such Company, without the aid, application or use
of any item of such Company's Proprietary Information, as evidenced by written records; now, or subsequently becomes, through
no act or failure to act on the part of the Candidate, generally known or available; is disclosed to the Candidate by a third
party authorized to disclose it; or is required by law or by court or administrative order to be disclosed; provided, that the
Candidate shall have first given prompt notice to such Company of such required disclosure.

    	 	2	 

     

    

(c)
Candidate shall exercise due care to prevent
the unauthorized use or disclosure of the Company's Proprietary Information, and shall not, without the Company's prior written
consent, disclose or otherwise make available, directly or indirectly, any item of the Company's Proprietary Information to any
person or entity other than those employees, independent contractors or agents of the Candidate (collectively, "Representatives"),
to the extent such Representatives reasonably need to know the same in order to evaluate such Proprietary Information, to participate
in the business relationship between the parties, or to make decisions or render advice in connection therewith. Candidate shall
advise its Representatives who have access to the Company's Proprietary Information of the confidential and proprietary nature
thereof, and agrees that such Representatives shall be bound by terms of confidentiality and restrictions on use with respect
thereto that are at least as restrictive as the terms of this Agreement.

 

(d)
Candidate shall exercise due care to prevent
the unauthorized use or disclosure of the Company's Proprietary Information, and shall not, without the Company's prior written
consent, disclose or otherwise make available, directly or indirectly, any item of the Company's Proprietary Information to any
person or entity other than those employees, independent contractors or agents of the Candidate (collectively, "Representatives"),
to the extent such Representatives reasonably need to know the same in order to participate in any business relationship between
the parties, or to make decisions or render advice in connection therewith. Candidate shall advise its Representatives who have
access to the Company's Proprietary Information of the confidential and proprietary nature thereof, and agrees that such Representatives
shall be bound by terms of confidentiality and restrictions on use with respect thereto that are at least as restrictive as the
terms of this Agreement.

 

(e)
Candidate shall use the Company's Proprietary
Information solely for the purposes of performing his duties pursuant to this Agreement and shall not make any other use of the
Company's Proprietary Information without the Company's specific written authorization.

 

(f)
All Proprietary Information of the Company (including
all copies thereof) shall be and at all times remain the property of such Company, and all non-oral Proprietary Information of
the Company which is then in the Candidate's possession or control shall be destroyed or returned to the Company promptly upon
its request at any time, and in any event, no later than 60 days following any expiration or termination of this Agreement.

 

(g)
Nothing in this Agreement shall be construed,
by implication or otherwise, as a grant of any right or license to trademarks, inventions, copyrights or patents, as a grant of
a license to either Candidate to use any of the Company's Proprietary Information except as expressly set forth herein.

 

(h)
The provisions of Section 7 of this Agreement
shall survive until such time as all Confidential Information disclosed hereafter becomes publically known and made generally
available through no action or inaction of Candidate.

    	 	3	 

     

    

		8.	Compensation.

		(a)	For
                                         performance of duties pursuant to Section 1 of this Agreement, Candidate will receive,
                                         no later than ten days from the execution of this agreement, 1,000,000 shares of Series
                                         M Preferred stock of the Company. In addition, on the first, second and third anniversary
                                         of this agreement, the Candidate shall receive an additional l,000,000 shares of Series
                                         M Preferred stock of the Company (for a total of 4,000,000 shares during the term of
                                         this agreement). The Series M Preferred shares are convertible into common shares of
                                         the Company upon either a) the execution of a licensing agreement for the Company's NR2F6
                                         intellectual property, or, b) upon the third anniversary of this agreement.

		(b)	For
                                         performance of duties pursuant to Section 2 of this Agreement, Candidate will receive:

		(i)	In
                                         the event that an Advisory Candidate identified and introduced by the Candidate to the
                                         Company serves as a member of the Business Advisory Board of the Company, you shall receive,
                                         ten business days subsequent to the completion of 12 months service by the Advisory Candidate
                                         as a member of the Business Advisory Board of the Company, a referral fee equal to 5%
                                         (paid to you in Series A Preferred shares of the Company) of the shares of the common
                                         shares of the Company issued to the referred Candidate.

		(ii)	In
                                         the event of a Transaction with one or more Buyers of the Company's securities, such
                                         Buyers not previously known to the Company and identified and introduced by you to the
                                         Company, a referral fee equal to 5% (paid to you in Series A Preferred shares of the
                                         Company) of the shares of common stock of the Company purchased by the Buyer.

		9.	Restricted
                                         Securities Acknowledgement

 

Candidate
acknowledges that any securities issued pursuant to this Agreement that shall not be registered pursuant to the Securities Act
of 1933 shall constitute "restricted securities" as that term is defined in Rule 144 promulgated under the Securities
Act of 1933, and shall contain the following restrictive legend:

 

"THESE
SECURITIES HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE "ACT"), OR SECURITIES LAWS OF
ANY STATE AND MAY NOT BE OFFERED, SOLD, ASSIGNED, PLEDGED, TRANSFERRED OR OTHERWISE DISPOSED OF IN THE ABSENCE OF AN EFFECTIVE
REGISTRATION STATEMENT UNDER THE ACT AND APPLICABLE STATE SECURITIES LAWS OR PURSUANT TO AN AVAILABLE EXEMPTION FROM REGISTRATION
UNDER THE ACT OR SUCH LAWS AND, IF REQUESTED BY THE COMPANY, UPON
DELIVERY OF AN OPINION OF COUNSEL REASONABLY SATISFACTORY TO THE COMPANY THAT THE PROPOSED TRANSFER IS EXEMPT FROM THE ACT OR
SUCH LAWS."

    	 	4	 

     

    

 

 

		10.	Representations
                                         And Warranties Of Company.

 

a)
Company is a corporation duly organized, validly existing and in good standing under the laws of the state its incorporation and
has the requisite corporate power and authority to enter into and perform its obligations under this Agreement without the consent,
approval or authorization of, or obligation to notify, any person, entity or governmental agency which consent has not been obtained.

 

(c)
The execution, delivery and performance of this
Agreement by Company does not and shall not constitute Company's breach of any statute or regulation or ordinance of any governmental
authority, and shall not conflict with or result in a breach of or default under any of the terms, conditions, or provisions of
any order, writ, injunction, decree, contract, agreement, or instrument to which the Company is a party, or by which Company is
or may be bound.

		11.	Representation
                                         and Warranties of the Candidate.

 

(a) 
Candidate has the requisite power and authority
to enter into and perform his obligations under this Agreement without the consent, approval or authorization of, or obligation
to notify, any person, entity or governmental agency which consent has not been obtained.

 

(b)
The execution, delivery and performance of this
Agreement by Candidate does not and shall not constitute Candidate's breach of any statute or regulation or ordinance of any governmental
authority, and shall not conflict with or result in a breach of or default under any of the terms, conditions, or provisions of
any order, writ, injunction, decree, contract, agreement, or instrument to which the Candidate is a party, or by which Candidate
is or may be bound.

 

		12.	Execution

 

This
Agreement may be executed in two or more counterparts, all of which when taken together shall be considered one and the same Agreement
and shall become effective when counterparts have been signed by each party and delivered to the other party, it being understood
that both parties need not sign the same counterpart. In the event that any signature is delivered by facsimile transmission,
such signature shall create a valid and binding obligation of the party executing (or on whose behalf such signature is executed)
with the same force and effect as if such facsimile signature page were an original thereof.

 

		13.	Entire
                                         Agreement

This
Agreement constitutes a final written expression of all the terms of the Agreement between the parties regarding the subject matter
hereof, are a complete and exclusive statement of those terms, and supersedes all prior and contemporaneous Agreements, understandings,
and representations between the parties.

 

    	 	5	 

     

    

 

 

		14.	Severability

 

If
any provision of this Agreement is held to be invalid or unenforceable in any respect, the validity and enforceability of the
remaining terms and provisions of this Agreement shall not in any way be affected or impaired thereby and the parties will attempt
to agree upon a valid and enforceable provision that is a reasonable substitute therefore, and upon so agreeing, shall incorporate
such substitute provision in this Agreement

 

		15.	Governing
                                         Law, Venue, Waiver Of Jury Trial

 

All
questions concerning the construction, validity, enforcement and interpretation of this Agreement shall be governed by and construed
and enforced in accordance with the internal laws of the State of California, without regard to the principles of conflicts of
law thereof. Each party hereby irrevocably submits to the exclusive jurisdiction of the state and federal courts sitting in California
for the adjudication of any dispute hereunder or in connection herewith or with any transaction contemplated hereby or discussed
herein and hereby irrevocably waives, and agrees not to assert in any suit, action or proceeding, any claim that it is not personally
subject to the jurisdiction of any such court, that such suit, action or proceeding is improper or inconvenient venue for such
proceeding. If either party shall commence an action or proceeding to enforce any provisions of this Agreement, then the prevailing
party in such action or proceeding shall be reimbursed by the other party for its attorneys' fees and other costs and expenses
incurred with the investigation, preparation and prosecution of such action or proceeding.

 

IN
WITNESS WHEREOF, the parties hereto have caused this Agreement to be duly executed by their respective authorized signatories
as of the date first indicated above.

 

 

	COMPANY	 	CANDIDATE
	By:	 	 
	 	 	 
	 	 	 
	 	 	/s/ Robert
    D Hopkins
	Its:	 	 
	Date:	 	Date: October 4, 2017
	 	 	 

 

    	 	6

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00278-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00278-of-00352.parquet"}]]